Showing results (191-200 of 248) with videos related to

Sort By:
Pageof 25
Journal of Clinical Medicine|April 12, 2022
Radiomics-Based Image Phenotyping of Kidney Apparent Diffusion Coefficient Maps: Preliminary Feasibility & EfficacyLu-Ping Li, Alexander S Leidner, Emily Wilt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 22, 2009
Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HClStuart M Sprague, Pieter Evenepoel, Mario P Curzi, et al.
Cancer Research|April 1, 1992
Tempol, a stable free radical, is a novel murine radiation protectorS M Hahn, Z Tochner, C M Krishna, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 1994
Effects of intraoperative radiotherapy on vascular grafts in a canine modelP A Johnstone, M Sprague, A M DeLuca, et al.
Paediatric Drugs|May 24, 2023
Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES SurveyMichael A Haft, Helen H Park, Stephanie S Lee, et al.
American Journal of Nephrology|October 5, 2007
Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysisEdward A Ross, Jin Tian, Hanna Abboud, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 16, 2010
touché Is required for touch-evoked generator potentials within vertebrate sensory neuronsSean E Low, Joel Ryan, Shawn M Sprague, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2006
Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKDDaniel Coyne, Muralidhar Acharya, Ping Qiu, et al.
Developmental Neurobiology|March 13, 2010
Na(v)1.6a is required for normal activation of motor circuits normally excited by tactile stimulationSean E Low, Weibin Zhou, Ingxin Choong, et al.
American Journal of Nephrology|September 28, 2016
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney DiseaseStuart M Sprague, Paul W Crawford, Joel Z Melnick, et al.
Pageof 25